|
WO0232433A1
|
|
Drug delivery system
|
|
AU5844201A
|
|
Drug delivery device, especially for the delivery of levonorgestrel
|
|
FI20002361A0
|
|
A process for preparing a pharmaceutical composition and the use of the composition
|
|
FI20002362A0
|
|
A process for preparing a pharmaceutical composition and the use of the composition
|
|
US6299894B1
|
|
Drug delivery device, especially for the delivery of gestodene
|
|
FI20000572A0
|
|
Device intended for application of implants
|
|
US6476079B1
|
|
Devices for the delivery of drugs having antiprogestinic properties
|
|
US6117442A
|
|
Drug delivery device, especially for the delivery of androgens
|
|
US6056976A
|
|
Elastomer, its preparation and use
|
|
US6063395A
|
|
Drug delivery device especially for the delivery of progestins and estrogens
|
|
CZ20001245A3
|
|
Anhydride derivatives of methylenebisphosphonic acid, process of their preparation and pharmaceutical preparation containing thereof
|
|
FI981506A0
|
|
Drug-permeable membrane or matrix for drug delivery
|
|
FI974664A0
|
|
Process for the preparation of a pharmaceutical formulation
|
|
FI974610A0
|
|
Pharmaceutical preparations in gelform
|
|
FI974001A0
|
|
New methylene bisphosphonic acid derivatives
|
|
FI973733A0
|
|
Tablet and process for its preparation
|
|
FI973000A0
|
|
New medical use of hemic products
|
|
FI963745A
|
|
Ophthalmic composition containing an ion-sensitive hydrophilic polymer and an inorganic salt in a low viscosity ratio
|
|
US5719196A
|
|
Method of treating respiratory infections or complications derived therefrom in humans which includes oral administration of xylitol
|
|
CA2192456A1
|
|
Pyridylbisphosphonates for use as a therapeutical agent
|
